Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
Day 1 Hour 1-2: Immediate Assessment and Information Gathering Objective: Gather all available data on the side effect, including the internal research report, patient case studies, and any existing literature. Reasoning: A comprehensive understanding of the situation is crucial for informed decision-making.Read the full answer
As CEO, I would not wait six months and I would not let the board delay disclosure while patients remain exposed to an unreported serious risk. I would treat this as a patient-safety, regulatory, legal, and trust crisis—not merely a financial-risk issue. My guiding decisions would be: Patient safety comes first.Read the full answer